Goldman Sachs’s Hims & Hers Health HIMS Stock Holding History

Goldman Sachs’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.8M	Buy	2,733,100 +2,608,600	+2,095%	+$70M	0.01%	1258
2026 Q1	$2.58M	Sell	124,500 -475,500	-79%	-$11.2M	﹤0.01%	4306
2025 Q4	$19.5M	Buy	600,000 +343,600	+134%	+$14.7M	﹤0.01%	2400
2025 Q3	$14.5M	Buy	256,400 +49,500	+24%	+$2.54M	﹤0.01%	2589
2025 Q2	$10.3M	Buy	206,900 +84,900	+70%	+$3.84M	﹤0.01%	2729
2025 Q1	$3.61M	Buy	122,000 +22,000	+22%	+$817K	﹤0.01%	3663
2024 Q4	$2.42M	Buy	+100,000	New	+$2.48M	﹤0.01%	4119
2021 Q4	–	Sell	-450,000	Closed	-$3.39M	–	6553
2021 Q3	$3.39M	Buy	+450,000	New	+$3.81M	﹤0.01%	3699

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Goldman Sachs's HIMS Position: Q2 2026 in Review

Goldman Sachs increased its Hims & Hers Health (HIMS) stake by 111% in Q2 2026, buying an estimated $73M and bringing the position to 5,173,865 shares worth $179M. The position accounts for 0.02% of the portfolio, ranked #829.

Goldman Sachs first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $523M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Goldman Sachs held 5,173,865 shares of Hims & Hers Health worth $179M as of Q2 2026.
Goldman Sachs bought 2,719,170 Hims & Hers Health shares in Q2 2026, an estimated $73M.
Hims & Hers Health made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #829 holding.
Goldman Sachs first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
Goldman Sachs's Hims & Hers Health position peaked at $523M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.